Francesca Branzoli1,2, Dinesh K Deelchand3, Marc Sanson2,4,5, Stéphane Lehéricy1,2,6, Małgorzata Marjańska3. 1. Institut du Cerveau et de la Moelle épinère-ICM, Centre de NeuroImagerie de Recherche-CENIR, Paris, France. 2. Sorbonne Université, UMR S 1127, Inserm U 1127, CNRS UMR 7225, ICM, Paris, France. 3. Center for Magnetic Resonance Research and Department of Radiology, University of Minnesota, Minneapolis, Minnesota. 4. AP-HP, Hôpital de la Pitié-Salpêtrière, Service de Neurologie 2, Paris, France. 5. Onconeurotek Tumor Bank, Institut du Cerveau et de la Moelle épinère-ICM, Paris, France. 6. AP-HP, Hôpital de la Pitié-Salpêtrière, Service de Neuroradiologie, Paris, France.
Abstract
PURPOSE: To report the technical aspects of noninvasive detection of cystathionine in human brain glioma with edited MRS, and to investigate possible further acquisition improvements for robust quantification of this metabolite. METHODS: In vivo 1 H MR spectra were acquired at 3 T in 15 participants with an isocitrate dehydrogenase-mutated glioma using a MEGA-PRESS (MEscher GArwood point resolved spectroscopy) sequence previously employed for 2-hydroxyglutarate detection (TR = 2 s, TE = 68 ms). The editing pulse was applied at 1.9 ppm for the edit-on condition and at 7.5 ppm for the edit-off condition. To evaluate the editing efficiency, spectra were acquired in 1 participant by placing the editing pulse for the edit-on condition at 1.9, 2.03, and 2.16 ppm. Cystathionine concentration was quantified using LCModel and a simulated basis set. To confirm chemical shifts and J-coupling values of cystathionine, the 1 H NMR cystathionine spectrum was measured using a high-resolution 500 MHz spectrometer. RESULTS: In 12 gliomas, cystathionine was observed in the in vivo edited MR spectra at 2.72 and 3.85 ppm and quantified. The signal intensity of the cystathionine resonance at 2.72 ppm increased 1.7 and 2.13 times when the editing pulse was moved to 2.03 and 2.16 ppm, respectively. Cystathionine was not detectable in normal brain tissue. CONCLUSION: Cystathionine can be detected in vivo by edited MRS using the same protocol as for 2-hydroxyglutarate detection. This finding may enable a more accurate, noninvasive investigation of cellular metabolism in glioma.
PURPOSE: To report the technical aspects of noninvasive detection of cystathionine in humanbrain glioma with edited MRS, and to investigate possible further acquisition improvements for robust quantification of this metabolite. METHODS: In vivo 1 H MR spectra were acquired at 3 T in 15 participants with an isocitrate dehydrogenase-mutated glioma using a MEGA-PRESS (MEscher GArwood point resolved spectroscopy) sequence previously employed for 2-hydroxyglutarate detection (TR = 2 s, TE = 68 ms). The editing pulse was applied at 1.9 ppm for the edit-on condition and at 7.5 ppm for the edit-off condition. To evaluate the editing efficiency, spectra were acquired in 1 participant by placing the editing pulse for the edit-on condition at 1.9, 2.03, and 2.16 ppm. Cystathionine concentration was quantified using LCModel and a simulated basis set. To confirm chemical shifts and J-coupling values of cystathionine, the 1 H NMR cystathionine spectrum was measured using a high-resolution 500 MHz spectrometer. RESULTS: In 12 gliomas, cystathionine was observed in the in vivo edited MR spectra at 2.72 and 3.85 ppm and quantified. The signal intensity of the cystathionine resonance at 2.72 ppm increased 1.7 and 2.13 times when the editing pulse was moved to 2.03 and 2.16 ppm, respectively. Cystathionine was not detectable in normal brain tissue. CONCLUSION:Cystathionine can be detected in vivo by edited MRS using the same protocol as for 2-hydroxyglutarate detection. This finding may enable a more accurate, noninvasive investigation of cellular metabolism in glioma.
Authors: Akshay Madan; Sandeep K Ganji; Zhongxu An; Kevin S Choe; Marco C Pinho; Robert M Bachoo; Elizabeth M Maher; Changho Choi Journal: Magn Reson Med Date: 2014-07-07 Impact factor: 4.668
Authors: Ovidiu C Andronesi; Grace S Kim; Elizabeth Gerstner; Tracy Batchelor; Aria A Tzika; Valeria R Fantin; Matthew G Vander Heiden; A Gregory Sorensen Journal: Sci Transl Med Date: 2012-01-11 Impact factor: 17.956
Authors: In-Young Choi; Ovidiu C Andronesi; Peter Barker; Wolfgang Bogner; Richard A E Edden; Lana G Kaiser; Phil Lee; Małgorzata Marjańska; Melissa Terpstra; Robin A de Graaf Journal: NMR Biomed Date: 2020-09-18 Impact factor: 4.044
Authors: Gilbert Hangel; Cornelius Cadrien; Philipp Lazen; Julia Furtner; Alexandra Lipka; Eva Hečková; Lukas Hingerl; Stanislav Motyka; Stephan Gruber; Bernhard Strasser; Barbara Kiesel; Mario Mischkulnig; Matthias Preusser; Thomas Roetzer; Adelheid Wöhrer; Georg Widhalm; Karl Rössler; Siegfried Trattnig; Wolfgang Bogner Journal: Neuroimage Clin Date: 2020-09-15 Impact factor: 4.881